News Biotech eyes Chinese opportunities and seek local partners Biotech companies see China as one of the biggest healthcare opportunities, but would need partnerships before approaching the market, a new report suggests.
News FDA approves new treatment for rare genetic disease PKU Novel enzyme therapy will treat adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment.
Partner Content Partner Content Wellcome Genome Campus Hackathon 2-3 July Sign up now for the Wellcome Genome Campus Hackathon
Partner Content Partner Content The Microbiome Movement – Skin Health & Dermatology Summ... Join The Microbiome Movement
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.